Pilot Safety Evaluation of a Novel Strain of
Overview
Affiliations
ELH-B2 is considered as a potential next-generation probiotic due to its preventive effects on lipopolysaccharides-associated inflammation and intestinal microbiota disorders in mice. To study safety issues associated with ELH-B2, we conducted comprehensive and systematic experiments, including genetic assessments of potential virulence and antimicrobial resistance genes, and an acute toxicity study of both immunocompetent and immunosuppressed mice via cyclophosphamide treatment. The results indicated that this novel strain is non-toxigenic, fragilysin is not expressed, and most of potential virulence genes are correlated with cellular structures such as capsular polysaccharide and polysaccharide utilizations. The antibiotic resistance features are unlikely be transferred to other intestinal microorganisms as no plasmids nor related genomic islands were identified. Side effects were not observed in mice. ELH-B2 also alleviated the damages caused by cyclophosphamide injection.
Unraveling Whole-Genome Sequence and Functional Characterization of PH3.
Zhang X, Liang J, Zhang D, Wang L, Ye S Foods. 2024; 13(22).
PMID: 39593971 PMC: 11593290. DOI: 10.3390/foods13223555.
Non-lactic acid bacteria probiotics isolated from intestine or various circumstances.
Lee N, Jang H, Paik H Food Sci Biotechnol. 2024; 33(9):1997-2007.
PMID: 39130655 PMC: 11315843. DOI: 10.1007/s10068-024-01608-x.
Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
Aliwa B, Horvath A, Traub J, Feldbacher N, Habisch H, Fauler G J Cachexia Sarcopenia Muscle. 2023; 14(6):2676-2691.
PMID: 37767786 PMC: 10751428. DOI: 10.1002/jcsm.13342.
Shahi F, Forrester S, Redeker K, Chong J, Barlow G Wellcome Open Res. 2023; 7:50.
PMID: 36874581 PMC: 9975432. DOI: 10.12688/wellcomeopenres.17450.3.
Ling Z, Cheng Y, Chen F, Yan X, Liu X, Shao L Front Immunol. 2022; 13:964910.
PMID: 36059521 PMC: 9437487. DOI: 10.3389/fimmu.2022.964910.